Athens Medical Group: Unique private healthcare provider in the European Union research program “EVOTION”
The European Union research program “EVOTION” is completed
Athens, January 31, 2020 – The three-year European Union research program “EVOTION” is successfully completed, in which the Athens Medical Group is the only private clinical healthcare provider participating pan-European.
It is noted that «EVOTION» is part of «Horizon 2020», the largest European program in the history of the European Union for research and technology, with total investments of more than 80 billion euros, in the seven-year period 2014 – 2020, aiming at Europe’s global competitiveness.
The head of the scientific team of the Athens Medical Center, Dr. George Gavalas, Director of Otology, Audiology and Neurootology at the Athens Medical Center, stated: “We are particularly pleased to participate in this pan-European, pioneering action, which aims to effectively address the 5th most common cause of disability, hearing loss, significantly improving the quality of life of thousands of people. The experience of the Athens Medical Center in this sensitive field is undeniable and was a key criterion for our selection.”
Dr. Vasilis Apostolopoulos, CEO of the Athens Medical Group, emphasized: “Faithful to the Athens Medical Group’s commitment to continuously invest in medical innovation and leadership, we participate in “EVOTION”, a European program – a breakthrough in the development of medical science and in the formulation of macroeconomic health policy, at the level of European Union countries. Within the framework of the Group’s strategic planning, we actively participate and contribute to the transmission of scientific knowledge, the utilization of new wearables and big data analysis technologies, thus leading the way in the most modern medical trend, that of Precision Medicine”.
Evotion Program
The Athens Medical Group participates together with 12 university departments, companies and institutions from 8 countries in the research program of the European Union “EVOTION”, including the company Oticon A/S, the National and Kapodistrian University of Athens, the City University of London, the University College London, the Nofer Institute of Occupational Medicine, the Institute of Public Health for the Osijek-Baranya County and the Università degli Studi di Milano (UNIMI). The aim of the program is to contribute to the formulation of Public Health policies related to Hearing Loss, as well as the way in which they are managed by professionals in the field and health institutions.
For more journalistic information:
Savvas Karagiannis, Communications Manager, General Directorate of Business Development of Iatriko Athens Group
Tel.: 210 6287236, E-mail: s.karagiannis@iatriko.gr
